V.HEART enables biomedical industries to conduct large-scale, high-throughput cardiac clinical trials on human models and populations from day one
ELEM has raised €1.2M across 1 funding round from 1 investor, most recently a Crowdfunding round in Dec 2021. Based in Barcelona, Spain; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-12-20 | Crowdfunding |
| €1.2M |
| Capital Cell |
| View deal → |
